Catalogo dei prodotti della ricerca

TRIVEDI, PANKAJ
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.145
EU - Europa 1.081
AS - Asia 502
AF - Africa 38
SA - Sud America 16
OC - Oceania 2
Totale 4.784
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.132
IT - Italia 401
SE - Svezia 226
SG - Singapore 223
IN - India 151
UA - Ucraina 120
CN - Cina 104
FI - Finlandia 80
DE - Germania 47
AT - Austria 39
ES - Italia 31
TG - Togo 31
IE - Irlanda 28
GB - Regno Unito 27
BG - Bulgaria 20
RU - Federazione Russa 18
AR - Argentina 16
ID - Indonesia 13
RO - Romania 12
CA - Canada 11
FR - Francia 10
BE - Belgio 7
GR - Grecia 5
BJ - Benin 4
JP - Giappone 4
CH - Svizzera 3
CY - Cipro 3
CZ - Repubblica Ceca 2
KR - Corea 2
AU - Australia 1
EG - Egitto 1
HR - Croazia 1
LT - Lituania 1
LV - Lettonia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SC - Seychelles 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 4.784
Salva come PNG Salva come JPEG
Città #
Fairfield 623
Ashburn 261
Woodbridge 257
Houston 246
Rome 226
Chandler 220
Seattle 192
Singapore 165
Ann Arbor 153
Wilmington 138
Cambridge 128
Dearborn 82
Princeton 71
Plano 57
Jacksonville 48
Boston 46
Lawrence 46
Santa Clara 46
San Paolo di Civitate 41
San Diego 39
Vienna 34
Lomé 31
Barcelona 30
Helsinki 30
Dublin 27
Andover 25
Beijing 24
New York 21
Millbury 20
Sofia 20
Hyderabad 18
Washington 15
Boardman 14
Federal 13
Jakarta 13
Bremen 11
Gainesville 10
Des Moines 9
Hefei 8
Latina 8
Moscow 8
Norwalk 8
Brussels 7
Fremont 7
Toronto 7
Trento 7
Falls Church 6
Miami 6
Munich 6
Nanchang 6
Nanjing 6
Naples 6
Athens 5
Guangzhou 5
Mentana 5
Phoenix 5
Brescia 4
Bühl 4
Chongqing 4
Cotonou 4
Falkenstein 4
Genoa 4
Jinan 4
Nuremberg 4
Redwood City 4
Shanghai 4
Stockholm 4
Altavilla Vicentina 3
Ariccia 3
Buenos Aires 3
Changsha 3
Civitavecchia 3
Fasano 3
Florence 3
Grafing 3
Kunming 3
Limassol 3
London 3
Los Angeles 3
Wenzhou 3
Anguillara 2
Atlanta 2
Bellême 2
Berlin 2
Bern 2
Champs-sur-marne 2
Dallas 2
Edinburgh 2
Frankfurt am Main 2
Garbagnate Milanese 2
Genazzano 2
Lappeenranta 2
Mannheim 2
Monza 2
Ottawa 2
Provo 2
Riva 2
Shenyang 2
Thatcham 2
Ueuchi 2
Totale 3.689
Salva come PNG Salva come JPEG
Nome #
Hydrophilic gold nanoparticles as Anti-PD-L1 antibody carriers. Synthesis and interface properties 123
Epstein-Barr virus encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B cell lymphomas 111
Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells 109
Different outcome of targeting ERN1/IRE1 alpha and EIF2AK3/PERK in NSG mice engrafted with primary effusion lymphoma 105
Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth in vitro and in vivo 101
Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2 100
Epstein-Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells. 100
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in multiple sclerosis 99
Activation of dendritic cells by tumor cell death 97
Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future 95
EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: Implications for viral immune escape 93
MiR-200c-3p contrasts PD-L1 induction by combinatorial therapies and slows proliferation of epithelial ovarian cancer through downregulation of β-Catenin and c-Myc 91
Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b 90
T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus carrying Burkitt lymphoma lines 88
MiR-200c-3p maintains stemness and proliferative potential in adipose-derived stem cells by counteracting senescence mechanisms 87
EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells 86
DECREASED EXPRESSION OF E-CADHERIN AND INCREASED INVASIVE CAPACITY IN EBV-LMP-TRANSFECTED HUMAN EPITHELIAL AND MURINE ADENOCARCINOMA CELLS 85
DENDRITIC CELL DIFFERENTIATION BLOCKED BY PRIMARY EFFUSION LYMPHOMA-RELEASED FACTORS IS PARTIALLY RESTORED BY INHIBITION OF P38 MAPK 85
Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells. 84
HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma 84
Characterization of Epstein–Barr virus genotypes in multiple sclerosis through next generation sequencing approaches 83
Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activity 83
Epstein-Barr virus and plasmacytoid dendritic cells: A possible duet in autoimmunity 83
Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein-Barr virus. 82
Epstein-Barr virus: From kisses to cancer, an ingenious immune evader 82
Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells 77
EXPRESSION OF THE EPSTEIN-BARR-VIRUS (EBV)-ENCODED MEMBRANE ANTIGEN (LMP) INCREASES THE STIMULATORY CAPACITY OF EBV-NEGATIVE B-LYMPHOMA LINES IN ALLOGENEIC MIXED LYMPHOCYTE-CULTURES 76
CS16-6. Plasmacytoid Dendritic Cells are infected by Epstein Barr virus and induces TLR- dependent type I IFN production 76
Abstract A16: Epstein-Barr virus encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B cell lymphomas 75
Differential regulation of Epstein-Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain 75
HHV-8 reduces dendritic cell migration through down-regulation of cell-surface CCR6 and CCR7 and cytoskeleton reorganization 74
Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses. 73
Meet our Associate Editor 73
Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression 71
The Nefarious Nexus of Noncoding RNAs in Cancer 70
Downregulation of COX-2 and JNK expression after induction of ischemic tolerance in the gerbil brain 70
Thyroid hormones interaction with immune response, inflammation and non-thyroidal illness syndrome 70
Calcineurin gamma catalytic subunit ppp3cc inhibition by mir-200c-3p affects apoptosis in epithelial ovarian cancer 70
SAP expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is down-regulated during immunoblastic transformation. 68
Human herpesvirus 6 infection in neoplastic and normal brain tissue. 68
JNK and Macroautophagy Activation by Bortezomib Has a Pro-Survival Effect in Primary Effusion Lymphoma Cells 68
microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma 68
Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas 66
Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma cells 64
When viruses cross developmental pathways 64
THE EPSTEIN-BARR-VIRUS-ENCODED MEMBRANE-PROTEIN LMP BUT NOT THE NUCLEAR ANTIGEN EBNA-1 INDUCES REJECTION OF TRANSFECTED MURINE MAMMARY-CARCINOMA CELLS 62
Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex 62
Transformation associated Epstein-Barr virus antigens as targets for immune attack. 62
Epstein-Barr virus-encoded LMP1 protein upregulates the pNDCF group of nucleoskeleton-cytoskeleton-associated proteins 61
Mycophenolic acid (MPA) modulates host cellular autophagy progression in sub genomic dengue virus-2 replicon cells 61
SELECTIVE INDUCTION OF ALLOSTIMULATORY CAPACITY AFTER 5-AZAC TREATMENT OF EBV CARRYING BUT NOT EBV NEGATIVE BURKITT-LYMPHOMA CELL-LINES 61
Augmentation of leukocyte infiltration in murine tumors expressing B-cell derived but not nasopharygeal carcinoma derived EBV membrane protein LMP-1. 60
Primary Effusion Lymphoma Cell Death Induced by Bortezomib and AG 490 Activates Dendritic Cells through CD91 60
Differential immunogenicity of EBV encoded growth transformation associated latent proteins in a murine model system. 58
A long-term memory obtained by genetic immunization results in full protection from a mammary adenocarcinoma expressing an EBV gene 57
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain 55
Epstein-Barr virus growth transformation associated proteins: Effects on immunogenicity and phenotype of the tumor cells. Academic Thesis, Karolinska Institutet, 54
Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: An immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells. 54
INTEGRATION OF A SHORT EPSTEIN-BARR-VIRUS DNA FRAGMENT IN A B95-8 VIRUS CONVERTED BURKITT-LYMPHOMA LINE EXPRESSING EPSTEIN-BARR NUCLEAR ANTIGENS EBNA2 AND EBNA5 52
EPSTEIN-BARR-VIRUS (EBV)-ENCODED MEMBRANE-PROTEIN LMP1 FROM A NASOPHARYNGEAL CARCINOMA NONIMMUNOGENIC IN A MURINE MODEL SYSTEM, IN CONTRAST TO A B-CELL-DERIVED HOMOLOG 48
EXPRESSION OF BCL-2 IN BURKITTS-LYMPHOMA CELL-LINES - INDUCTION BY LATENT EPSTEIN-BARR-VIRUS GENES 45
Epstein-Barr virus encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma 43
EXPRESSION OF THE EPSTEIN-BARR-VIRUS (EBV)-ENCODED MEMBRANE-PROTEIN LMP1 IMPAIRS THE INVITRO GROWTH, CLONABILITY AND TUMORIGENICITY OF AN EBV-NEGATIVE BURKITT-LYMPHOMA LINE 42
MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma. 42
Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP. A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas 33
Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma 33
Comparative analysis of three methods in anti-dsDNA antibodies detection: implications for Systemic Lupus Erythematosus diagnosis 30
PARALLEL EXISTENCE OF EPSTEIN-BARR-VIRUS (EBV) POSITIVE AND NEGATIVE CELLS IN A SPORADIC CASE OF BURKITT-LYMPHOMA 28
Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers 16
null 15
Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID‑19 13
Hydrophilic gold nanoparticles as multimodal agents for plasmonic nanomedicine. Salamone TA., B. Pennacchi B, Mercurio M, Cerra S, Marotta S, Mrmic S, Alimandi M, Visco V, Taurino M, Trivedi P, I. Fratoddi I, Anastasiadou E 12
Possible steps required in the internalization of nude Epstein-Barr virus (EBV). 11
Perspecitve Chapter: Modulation of Latent to Lytic Cycle Infection Switch and its Implication in EBV Mediated Tumorigenicity 10
Understanding the role of membrane cholesterol upon Epstein Barr virus infection in astroglial cells. 9
RNA-aided immunotherapeutics 9
Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis 7
The interplay of co-infections in shaping COVID-19 severity: Expanding the scope beyond SARS-CoV-2 5
Totale 5.012
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 71
selected - selezionate 0
volume - volumi 0
Totale 14.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020531 0 0 0 0 0 0 150 127 108 81 40 25
2020/2021377 38 36 11 26 11 53 11 24 32 69 25 41
2021/2022936 3 46 78 113 97 22 17 79 50 52 251 128
2022/2023880 136 208 50 87 109 73 10 48 63 16 53 27
2023/2024535 48 53 33 28 58 98 12 37 17 51 37 63
2024/2025363 30 26 48 120 46 82 11 0 0 0 0 0
Totale 5.012